Reveal Biosciences is a computational pathology company combining traditional histopathology with machine learning to address enabling tissue biology to yield actionable data. The firm's technology pipeline includes a high-plex multiplex platform and machine learning computational pathology solutions to benefit cancer patients. Reveal provides advanced tissue technologies including immunohistochemistry (IHC), in situ hybridization (ISH), histology, digital pathology and image analysis services to a broad range of pharmaceutical, biotech, academic and government institutions. In May 2021 it was announced that Reveal Biosciences had been acquired by the Canadian firm CellCarta for an undisclosed amount.
